Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson’s disease model
Open accessThe DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
Mitochondrial complex I dysfunction is regarded as underlying dopamine neuron death in Parkinson’s disease models. However, inactivation of the Ndufs4 gene, which compromises complex I activity, does not affect the survival of dopamine neurons in culture or in the substantia nigra pars compacta of 5-wk-old mice. Treatment with piericidin A, a complex I inhibitor, does not induce selective dopamine neuron death in either Ndufs4+/+ or Ndufs4−/− mesencephalic cultures. In contrast, rotenone, another complex I inhibitor, causes selective toxicity to dopamine neurons, and Ndufs4 inactivation potentiates this toxicity. We identify microtubule depolymerization and the accumulation of cytosolic dopamine and reactive oxygen species as alternative mechanisms underlying rotenone-induced dopamine neuron death. Enhanced rotenone toxicity to dopamine neurons from Ndufs4 knockout mice may involve enhanced dopamine synthesis caused by the accumulation of nicotinamide adenine dinucleotide reduced. Our results suggest that the combination of disrupting microtubule dynamics and inhibiting complex I, either by mutations or exposure to toxicants, may be a risk factor for Parkinson’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, the CI inhibitor rotenone destabilizes microtubules, 40,41 and the CII inhibitor α-TOS as well as the complex III inhibitor antimycin act as BH3 mimetics.42,43”
From Ubiquinone-binding site mutagenesis reveals the role of mitochondrial complex II in cell death initiation (2015) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis
Gross, A., Jockel, J., Wei, M. C., & Korsmeyer, S. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.14.3878 · Cited by 1,086
Mechanism of Toxicity in Rotenone Models of Parkinson's Disease
Sherer, T. B., Betarbet, R., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., Miller, G. W., Yagi, T., Matsuno-Yagi, A., & Greenamyre, J. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10756.2003 · Cited by 1,072
Abnormalities of the electron transport chain in idiopathic parkinson's disease
Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,063
Expanding insights of mitochondrial dysfunction in Parkinson's disease
Abou-Sleiman, P. M., Muqit, M. M. K., & Wood, N. W. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1868 · Cited by 869 · cited 1×
“Inhibition of mitochondrial complex I has long been one of the leading theories (Abou-Sleiman et al., 2006).”
Keeney, P. M., Xie, J., Capaldi, R. A., & Bennett, J. P. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0984-06.2006 · Cited by 747
Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease
Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., Sato, T., Oya, H., Ozawa, T., & Kagawa, Y. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91141-8 · Cited by 739
Cited by
Items 101–200 of 207
Emerging targets and new small molecule therapies in Parkinson’s disease treatment
Zhang, H., Tong, R., Bai, L., Shi, J., & Ouyang, L. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.02.030 · Cited by 29
Linking microtubules to Parkinson's disease: the case of parkin
Cappelletti, G., Casagrande, F., Calogero, A. M., Gregorio, C. D., Pezzoli, G., & Cartelli, D. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150007 · Cited by 28
Cai, Y., Shen, H., Weng, H., Wang, Y.-Q., Cai, G., Chen, X., & Ye, Q. (2020) · Scientific Reports · doi:10.1038/s41598-020-67229-6 · Cited by 28
Rodriguez, M., Lapierre, J., Ojha, C. R., Pawitwar, S. S., Karuppan, M. K. M., Kashanchi, F., & El‐Hage, N. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-018-0715-4 · Cited by 27
Serrano‐García, N., Fernández‐Valverde, F., Luis‐García, E. R., Granados-Rojas, L., Juárez-Zepeda, T. E., Orozco-Suárez, S. A., Pedraza‐Chaverrí, J., Orozco‐Ibarra, M., & Jiménez‐Anguiano, A. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.10.015 · Cited by 26
Siwach, A., Patel, H., Khairnar, A., & Parekh, P. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70192 · Cited by 22
Guan, S., Xu, J., Guo, Y., Ge, D., Liu, T., Ma, X., & Cui, Z. (2015) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2015.02.008 · Cited by 22
Neuronal and astrocyte dysfunction diverges from embryonic fibroblasts in theNdufs4fky/fkymouse
Bird, M., Wijeyeratne, X. W., Komen, J. C., Laskowski, A., Ryan, M. T., Thorburn, D. R., & Frazier, A. E. (2014) · Bioscience Reports · doi:10.1042/bsr20140151 · Cited by 22
Calandria, J. M., Sharp, M., & Bazan, N. G. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0206-6 · Cited by 22
Rotenone inhibits primary murine myotube formation via Raf-1 and ROCK2
Grefte, S., Wagenaars, J. A. L., Jansen, R., Willems, P. H. G. M., & Koopman, W. J. H. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.03.010 · Cited by 21
Dopaminergic neurotoxic effects of 3-TFMPP derivatives
Majrashi, M., Almaghrabi, M., Fadan, M., Fujihashi, A., Lee, W., DeRuiter, J., Clark, C. R., & Dhanasekaran, M. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.07.052 · Cited by 21
Effect of Pesticides on the Aggregation of Mutant Huntingtin Protein
Deshmukh, R. S., Chaudhary, R. K., & Roy, I. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8252-2 · Cited by 20
Zhu, M., Zhang, D., Zhou, C. Y., & Chai, Z. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00737 · Cited by 20
Tian, W., & Chen, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.616820 · Cited by 19
Mitochondrial complex I defects increase ubiquitin in substantia nigra
Song, L., & Cortopassi, G. A. (2014) · Brain Research · doi:10.1016/j.brainres.2014.11.013 · Cited by 19
Casanova, Y., Negro, S., & Barcia, E. (2021) · Acta Pharmaceutica · doi:10.2478/acph-2022-0008 · Cited by 18
Zhang, G., Ma, C., Ma, L., Wei, D., Wu, Y., Li, Y., Xu, Z. H., Liu, Y., Cai, Y., Yu, E. Y.-W., et al. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04269 · Cited by 17
Chaves, R., Melo, T. Q., D’Unhao, A. M., Farizatto, K. L. G., & Ferrari, M. (2013) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2013-1958 · Cited by 17
Cartelli, D., Goldwurm, S., Casagrande, F., Pezzoli, G., & Cappelletti, G. (2012) · PLoS ONE · doi:10.1371/annotation/6db7193b-913a-42f2-aa7c-139d6e15142a · Cited by 17
Modelling biochemical features of mitochondrial neuropathology
Bird, M., Thorburn, D. R., & Frazier, A. E. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.017 · Cited by 16
Bongard, R. D., Townsley, M. I., & Merker, M. P. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.09.030 · Cited by 16
Epifane-de-Assunção, M. C., Bispo, A. G., Ribeiro‐dos‐Santos, Â., & Cavalcante, G. C. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04526-5 · Cited by 14
Panelli, D., Lorusso, F. P., Papa, F., Panelli, P., Stella, A., Caputi, M., Sardanelli, A. M., & Papa, S. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.12.001 · Cited by 13
Omoruyi, S. I., Enogieru, A. B., Hussein, A. A., & Ekpo, O. E. (2019) · Journal of African Association of Physiological Sciences · Cited by 12
Gopi, M., & Vanisree, A. J. (2020) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2020.101788 · Cited by 12
Morton, K. S., George, A. J., & Meyer, J. N. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103538 · Cited by 11
How to Use Respiratory Chain Inhibitors in Toxicology Studies—Whole-Cell Measurements
Żuberek, M., Paciorek, P., Rakowski, M., & Grzelak, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169076 · Cited by 11
Choi, W., Palmiter, R. D., & Xia, Z. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem2083oia6 · Cited by 11
Self-citationMuhayimana, S., Zhang, X., Xu, J., Xiong, H., Luan, S., Zhu, Q., & Huang, Q. (2019) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2019.03.002 · Cited by 10
Targeting Mitochondria through the Use of Mitocans as Emerging Anticancer Agents
Macasoi, I. G., Mioc, A., Mioc, M., Racoviceanu, R., Şoica, I., Chevereșan, A., Dehelean, C. A., & Dumitraşcu, V. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190712150638 · Cited by 10
Shitara, Y., Tonohora, Y., Goto, T., Yamada, Y., Miki, T., Makino, H., Miwa, M., & Komiya, T. (2012) · The Journal of Biochemistry · doi:10.1093/jb/mvs034 · Cited by 9
Coppedè, F., Bosco, P., Fuso, A., & Troen, A. M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/926082 · Cited by 9
Erber, L. N., Liu, S. X., Gong, Y., Tran, P., & Chen, Y. (2022) · Molecules · doi:10.3390/molecules27020484 · Cited by 8
Administration of rotenone enhanced voluntary alcohol drinking behavior in C57BL/6J mice
Yoshimoto, K., Ueda, S., Kitamura, Y., Inden, M., Hattori, H., Ishikawa, N., McLean, S., & Ikegaya, H. (2012) · Legal Medicine · doi:10.1016/j.legalmed.2012.03.005 · Cited by 8
(Alternative Approaches to Pesticide Use): Plant-Derived Pesticides
Sylvestre, M.-N., Adou, A. I., Brudey, A., Sylvestre, M., Pruneau, L., Gaspard, S., & Cebrián‐Torrejón, G. (2022) · Springer eBooks · doi:10.1007/978-3-031-07434-9_5 · Cited by 7
Omoruyi, S. I., Akinfenwa, A. O., Ekpo, O. E., & Hussein, A. A. (2023) · South African Journal of Botany · doi:10.1016/j.sajb.2023.03.042 · Cited by 7
Ray, A., Kambali, M., & Ravindranath, V. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6602 · Cited by 7
Disruption of intracellular signaling
Kanthasamy, A. G., Luo, J. D., Rokad, D., & Charli, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813602-7.00007-7 · Cited by 7
Ivashko‐Pachima, Y., Seroogy, K. B., Sharabi, Y., & Gozes, I. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01876-w · Cited by 7
Sharma, B., Gupta, P., Biswas, L., Verma, A. K., Pasha, A. M., Thota, P., & Medhi, B. (2023) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_314_23 · Cited by 6
Catapol: a promising natural neuroprotective agent for neurologic disorders
Li, W., & Zhou, X. (2025) · Acta Materia Medica · doi:10.15212/amm-2024-0097 · Cited by 6
Cohen, J. D., & Tanaka, Y. (2018) · Applied In Vitro Toxicology · doi:10.1089/aivt.2017.0028 · Cited by 6
Historical perspectives on the discovery and development of drugs to treat neurological disorders
Williams, M. J., & COYLE, J. T. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.008 · Cited by 6
Adult Endogenous Dopaminergic Neuroregeneration Against Parkinson’s Disease: Ideal Animal Models?
Vijayanathan, Y., Lim, S. M., Tan, M. P., Lim, F. T., Majeed, A. B. A., & Ramasamy, K. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00298-7 · Cited by 6
Pharmacological Benefits of Cinnamaldehyde: A Comprehensive Insight
Ali, A., Ismayel, S. M., Samama, M., Kumar, A., & Gupta, P. (2024) · Current Bioactive Compounds · doi:10.2174/0115734072322707240902074426 · Cited by 5
Transcranial Photobiomodulation for Neuromodulation of Brain Disorders: A Perspective
Ridder, D. D., Hamblin, M. R., & Vanneste, S. (2026) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2025.12.006 · Cited by 5
Meng, G., Tian, C., Wang, H., Xu, Y., Zhang, B., Shi, Q., Gao, C., Chen, C., Fan, X., Wang, J., et al. (2014) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0342-5 · Cited by 4
Singh, N., Lawana, V., Krishnan, N., Kanuri, S. H., Jin, H., Anantharam, V., Kanthasamy, A. G., & Kanthasamy, A. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13939-5_10 · Cited by 4
Nisar, R., Hanson, P. S., He, L., Taylor, R. W., Blain, P. G., & Morris, C. M. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1542-5 · Cited by 4
Kozhukhar, N., & ALEXEYEV, M. F. (2025) · Mitochondrial Communications · doi:10.1016/j.mitoco.2025.12.001 · Cited by 3
Gou, J., Chen, L., Xu, Y., Liao, B., Shen, Y., Tai, J., Zhang, J., & Zuo, A. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1799383 · Cited by 3
PINK1-Based Screen Shines Light on Autophagy Enhancers for Parkinson’s Disease
Haddad, D., & Nakamura, K. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.04.002 · Cited by 3
An exploratory study on the ability of manganese to supplement rotenone neurotoxicity in rats
Ibarra-Gutiérrez, M. T., Serrano-García, N., Alcaraz-Zubeldia, M., Pedraza‐Chaverrí, J., & Orozco‐Ibarra, M. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149017 · Cited by 3
Xie, S., Cao, W., Guo, J., Zhao, M., Wang, L., Liang, F., & Wang, Z. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05870-4 · Cited by 2
Briceño, A., Núñez, C., Cortés, K., Pallacán, P., Salinas, N., Millán, C., Vivanco, J. F., Caro, N., Segura‐Aguilar, J., & Paris, I. B. (2026) · Antioxidants · doi:10.3390/antiox15060739 · Cited by 2
Tarianyk, K. А. (2021) · Ukrainian Neurological Journal · doi:10.30978/unj2021-1-2-25 · Cited by 2
Kozak, М. R., Остапив, Д. Д., Mitina, N., Petruh, I. M., Volianiuk, K., Zaichenko, A., & Влизло, В. В. (2021) · Biopolymers and Cell · doi:10.7124/bc.000a61 · Cited by 2
Use of Arabidopsis to Model Hereditary Spastic Paraplegia and Other Movement Disorders
Gardiner, J. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00075-5 · Cited by 2
The Rotenone Model of Parkinson's Disease in Studying the Mechanisms of Nigrostriatal Cell Death
Abdel‐Salam, O. M. E. (2015) · Cited by 2
Ngo, D. M. (2018) · uO Research (University of Ottawa) · doi:10.20381/ruor-22179 · Cited by 2
Hypothesis of Ascension in Idiopathic Parkinson’s Disease
Klingelhoefer, L., & Reichmann, H. (2017) · Neurology International Open · doi:10.1055/s-0043-102389 · Cited by 1
Valenza, A., Pensabene, D., Rendina, F., Muzzi, M., Fracassi, A., Moreno, S., & Segatto, M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1895046 · Cited by 1
Neuronal Mitochondria are Different
Berman, S., & Hardwick, J. M. (2015) · Wiley eBooks · doi:10.1002/9781119017127.ch10 · Cited by 1
Histopathologic Changes in the Substantia Nigra Resulted by Paraquat Intoxication in Rat
Sabbagh, A., Tavasoly, A., Amoli, J. S., & Mardjanmehr, S. H. (2016) · The Neuroscience Journal of Shefaye Khatam · doi:10.18869/acadpub.shefa.4.4.41 · Cited by 1
Aszensionshypothese beim idiopathischen Parkinson-Syndrom
Klingelhoefer, L., & Reichmann, H. (2017) · Aktuelle Neurologie · doi:10.1055/s-0043-101907 · Cited by 1
The Anorectic Phenotype of the anx/anx Mouse Is Associated with Hypothalamic Dysfunction
Nilsson, I. A. K., Hökfelt, T. G. M., & Schalling, M. (2020) · Neuromethods · doi:10.1007/978-1-0716-0924-8_16 · Cited by 1
Nanoparticles as nanocarriers of resveratrol for alzheimer's disease
Andrade, S. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/0mxd-7757 · Cited by 1
Dopamine and Serotonin Metabolism in Parkinsonian Models
Barrigon, C. D. L. F. (2018) · UCL Discovery (University College London) · Cited by 1
Oxidative stress and therapeutic strategies in the context of neurodegenerative disease
de Matos, A. B. D. C. A. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Martins, S. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2013.tde-07022014-103631
Microdevices for Isolating Single Axons for the Study of Axonal Transport in Dopaminergic Neurons
Lu, X. (2013) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7ft8j1n
Oxidative Modification of Cytochrome c by Tetrahydropapaveroline, an Isoquinoline-Derived Neurotoxin
Kang, J. H. (2013) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2013.34.2.406
Zaminelli, T. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Alterations of Dopaminergic Synapse and Mitochondrial Structure by Parkinson's Disease Toxins
Lee, M. J., Colvin, R. A., & Lee, D. (2014)
Chaves, R. D. S. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-05012016-154631
da Silva, C. M. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2015.tde-09062015-144939
The Anorectic Phenotype of the anx/anx Mouse Is Related to Hypothalamic Dysfunction
Nilsson, I. A. K., Lindfors, C., Hökfelt, T. G. M., Schalling, M., & Johansen, J. E. (2012) · Neuromethods · doi:10.1007/978-1-62703-104-2_20
Sorscher, N. (2012) · ResearchWorks at the University of Washington (University of Washington)
Manjeri, G. R. (2017) · Radboud Repository (Radboud University)
Fu, D. (2012) · TSpace (University of Toronto)
Merzetti, E. M. (2016) · Memorial University Research Repository (Memorial University)
THE IMPACT OF Α-SYNUCLEIN ON MICROTUBULES:FROM DYNAMICS TO ULTRASTRUCTURE
Cantele, F. (2018) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/cantele-francesca-ortensia_phd2018-06-22
Natural and Synthetic GHSR1a Agonists as Neuroprotective Agents in Models of Parkinson's disease
Rees, D. J. (2017) · Cronfa (Swansea University) · doi:10.23889/suthesis.40946
Abd-Elhalim, D., Hussain, M. A., & Abdo, M. I. (2014) · Suez Canal University Medical Journal · doi:10.21608/scumj.2014.46493
The neurotoxic effects of Manganese and the novel protective role of Drp1 in the autophagy pathway
Sportelli, C. (2020) · PEARL (University of Plymouth) · doi:10.24382/1248
Pinnell, J. R. (2020) · PEARL (University of Plymouth) · doi:10.24382/362
Bahia, G. M. D. C., Correa, M. G., Gomes, R. D. C., Lobão, T. A., de Souza, R. D., Yamada, E. S., da Costa, E. T., Lopes, D. C. F., Filho, A. J. M., Gomes‐Leal, W., et al. (2024) · Preprints.org · doi:10.20944/preprints202407.2510.v1
Mitochondrial toxicants to model Parkinson’s disease
Currim, F., & Cannon, J. R. (2025) · Advances in neurotoxicology · doi:10.1016/bs.ant.2025.02.005
Aggarwal, S., Biswas, A., Kharbanda, N., Singh, N., Bisht, K. S., Dey, C., Khatri, S., Tiwari, A., & Maiti, T. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.22.678296
Onyelonu, I., Oladipo, G. S., & Oyakhire, M. O. (2025) · Journal of Experimental and Clinical Anatomy · doi:10.4314/jeca.v22i2.24
The role of alternative splicing and long non-coding RNAs in parkinson’s disease
Kavanagh, T. (2018) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/3687
Oster, S. (2017) · Qucosa (Saxon State and University Library Dresden)
Mechanistic insights into an axon death pathway controlled by NAD-related metabolism
Loreto, A. (2018) · Nottingham ePrints (University of Nottingham)
Casabella Sin, S. (2021) · The Oberta in Open Access (Universitat Oberta de Catalunya)
Halder, P., Mondal, R., Chakraborty, E., & Majumder, S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.29.696880
The impact of climate change on food security and nutritional deficiencies in movement disorders
Phokaewvarangkul, O., & Bhidayasiri, R. (2026) · International review of movement disorders · doi:10.1016/bs.irmvd.2026.03.001
Shanmuganathan, D. K., Pranav, D. H., & Ariharasivakumar, G. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100338
Metadata
- Authors
- Choi, W.-S., Palmiter, R. D., & Xia, Z.
- Affiliations
- Howard Hughes Medical Institute (US)
- Corresponding author
- Xia, Zhengui
- ORCID
- Palmiter, Richard D.
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2011-03-07
- Volume
- 192
- Issue
- 5
- Pages
- 873-882
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3051820
- OpenAlex
- W2126516300
- Cited by
- 183
- References
- 59
- Citations by year
- 2026: 10 · 2025: 8 · 2024: 3 · 2023: 6 · 2022: 9 · 2021: 9 · 2020: 8 · 2019: 10 · 2018: 11 · 2017: 9 · 2016: 12 · 2015: 21 · 2014: 19 · 2013: 16 · 2012: 27
- FWCI
- 13.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Institute of Mental Health (R01MH095840)
- National Institute of Environmental Health Sciences (P30 ES-07033, ES013696, R01ES012215, ES 012215, R01ES013696, P30ES007033)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD02274, P30HD002274)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- Parkinson's disease, mitochondrial complex I, NDUFS4, rotenone, piericidin A, microtubule depolymerization, microtubule dysfunction, substantia nigra pars compacta, reactive oxygen species, NADH accumulation, neurotoxicity
- MeSH terms
- Animals, Cytoplasm, Disease Models, Animal, Dopamine, Microtubules, NAD, Nerve Degeneration, Parkinson Disease, Rotenone, Substantia Nigra, 1-Methyl-4-phenylpyridinium, Reactive Oxygen Species, Electron Transport Complex I, Vesicular Monoamine Transport Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.